• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 25-NSE filed by LAIX Inc.

    4/22/22 10:36:32 AM ET
    $LAIX
    Service to the Health Industry
    Miscellaneous
    Get the next $LAIX alert in real time by email
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    UNITED STATES
    OMB APPROVAL
    OMB Number: 3235-0080
    Expires: March 31, 2018
    Estimated average burden
    hours per response: 1.7
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 25
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
    UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    Commission File Number 001-38657
    Issuer: LAIX Inc.
    Exchange: NEW YORK STOCK EXCHANGE LLC
    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
    Address: 3/F, Building B, No. 1687 Changyang Road
    Yangpu District 200090
    Telephone number:  
    (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
    American Depositary Shares, each representing fourteen Class A Ordinary Shares
    (Description of class of securities)
    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
    17 CFR 240.12d2-2(a)(1)
    17 CFR 240.12d2-2(a)(2)
    17 CFR 240.12d2-2(a)(3)
    17 CFR 240.12d2-2(a)(4)
    Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
    Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
    Pursuant to the requirements fo the Securities Exchange Act of 1934, NEW YORK STOCK EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
    2022-04-22 By Lauren Frawley Analyst, Market Watch and Proxy Compliance
    Date Name Title
    1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $LAIX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LAIX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LAIX
    SEC Filings

    See more
    • SEC Form SC 13E3 filed by LAIX Inc.

      SC 13E3 - LAIX Inc. (0001742056) (Subject)

      7/11/22 8:52:23 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • SEC Form 6-K filed by LAIX Inc.

      6-K - LAIX Inc. (0001742056) (Filer)

      6/27/22 4:02:01 PM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • SEC Form 6-K filed by LAIX Inc.

      6-K - LAIX Inc. (0001742056) (Filer)

      6/17/22 9:10:37 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous

    $LAIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by LAIX Inc. (Amendment)

      SC 13D/A - LAIX Inc. (0001742056) (Subject)

      7/8/22 1:51:02 PM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • SEC Form SC 13D filed by LAIX Inc.

      SC 13D - LAIX Inc. (0001742056) (Subject)

      6/23/22 6:03:17 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • SEC Form SC 13D/A filed by LAIX Inc. (Amendment)

      SC 13D/A - LAIX Inc. (0001742056) (Subject)

      6/21/22 6:17:08 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous

    $LAIX
    Leadership Updates

    Live Leadership Updates

    See more
    • Zhihu Inc. Announces Change of Independent Director

      BEIJING, May 27, 2025 (GLOBE NEWSWIRE) -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE:ZH, HKEX: 2390)), a leading online content community in China, today announced the appointment of Dr. Li-Lan Cheng as an independent director of the Company. Mr. Hanhui Sam Sun has resigned as an independent director of the Company, due to other professional endeavors. These changes are effective on May 27, 2025. For the committees under the board of directors, Dr. Li-Lan will serve as the chairman of the audit committee as well as a member of the compensation committee, nomination committee, and corporate governance committee. Dr. Li-Lan Cheng is currently an executive director and chief financial offic

      5/27/25 4:50:22 AM ET
      $YJ
      $ZH
      $JOBS
      $LAIX
      Other Specialty Stores
      Consumer Discretionary
      Business Services
      Diversified Commercial Services

    $LAIX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Zhihu Inc. Announces Change of Independent Director

      BEIJING, May 27, 2025 (GLOBE NEWSWIRE) -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE:ZH, HKEX: 2390)), a leading online content community in China, today announced the appointment of Dr. Li-Lan Cheng as an independent director of the Company. Mr. Hanhui Sam Sun has resigned as an independent director of the Company, due to other professional endeavors. These changes are effective on May 27, 2025. For the committees under the board of directors, Dr. Li-Lan will serve as the chairman of the audit committee as well as a member of the compensation committee, nomination committee, and corporate governance committee. Dr. Li-Lan Cheng is currently an executive director and chief financial offic

      5/27/25 4:50:22 AM ET
      $YJ
      $ZH
      $JOBS
      $LAIX
      Other Specialty Stores
      Consumer Discretionary
      Business Services
      Diversified Commercial Services
    • LAIX Inc. Announces Plan to Implement ADS Ratio Change

      SHANGHAI, Feb. 21, 2022 /PRNewswire/ -- LAIX Inc. ("LAIX" or the "Company") (NYSE:LAIX), an artificial intelligence (AI) company in China that creates and delivers products and services to popularize English learning, today announced that it plans to change the ratio of its American Depositary Shares ("ADSs") to its Class A ordinary shares (the "ADS Ratio"), par value US$0.001 per share, from the current ADS Ratio of one (1) ADS to one (1) Class A ordinary share to a new ADS Ratio of one (1) ADS to fourteen (14) Class A ordinary shares. A post-effective amendment to the ADS Registration Statement on Form F-6 will be filed with the SEC to reflect the change in the ADS Ratio. The Company antic

      2/21/22 7:00:00 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous
    • LAIX Inc. Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price

      SHANGHAI, Sept. 28, 2021 /PRNewswire/ -- LAIX Inc. ("LAIX" or the "Company") (NYSE:LAIX), an artificial intelligence (AI) company in China that creates and delivers products and services to popularize English learning, today announced that it has received a letter (the "Letter") from the New York Stock Exchange (the "NYSE") dated September 17, 2021 and further e-mail communication on the same date, notifying the Company that (i) it is below compliance standards due to the trading price of the Company's American depositary shares (the "ADSs"), and (ii) the applicable cure period for the Company to regain compliance expires on March 17, 2022. Pursuant to applicable NYSE continued listing stan

      9/28/21 7:00:00 AM ET
      $LAIX
      Service to the Health Industry
      Miscellaneous